TTrialPathMatch Me to Trials
← Back to trials
RecruitingHIV InfectionLiver Transplant

Expanding HOPE Liver

Eligible age

18+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a prospective, multicenter clinical study. The objective is to determine whether a liver transplant from a deceased donor with HIV is associated with an increased risk of opportunistic infection and cancer. Adults with Human Immunodeficiency Virus (HIV) in need of a liver or simultaneous liver-kidney (SLK) transplant who meet study-specified criteria will be offered enrollment in the study. The analytic plan includes an observational cohort of liver and SLK transplant recipients from prior HOPE in Action studies.

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

You may qualify if…

  • ✓ Recipient Inclusion Criteria
  • ✓ 1. Participant meets local criteria for liver or simultaneous liver kidney (SLK) transplant
  • ✓ 2. Participant or legally authorized representative (in accordance with Johns Hopkins Medicine Institutional Review Board (IRB) and local IRB policy) is able to understand and provide informed consent
  • ✓ 3. Participant has documented HIV infection by any licensed assay or documented history of detectable Human Immunodeficiency Virus (HIV)-1 Ribonucleic Acid (RNA)
  • ✓ 4. Participant is ≥ 18 years old
  • ✓ 5. Most recent HIV-1 RNA \<= 50 copies RNA/mL. Viral blips between 50-400 copies will be allowed as long as there are not consecutive measurements \> 200 copies/mL. Organ recipients who are unable to tolerate ART due to organ failure or recently started ART may have detectable viral load and still be eligible if a safe and effective antiretroviral regimen to be used by the recipient after transplantation is described
  • ✓ Deceased Donor Criteria
  • ✓ 1. Donation after brain death or cardiac death

You may not qualify if…

  • ✕ Recipient
  • ✕ 1. Participant has prior progressive multifocal leukoencephalopathy (PML), cryptosporidiosis of \> 1 month, or primary Central Nervous System (CNS) lymphoma
  • ✕ 2. Participant is pregnant or breastfeeding. Note: Participants who become pregnant post-transplant will be followed on study and managed per local site practice
  • ✕ 3. Past or current medical problems or findings from medical history, physical examination, or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study

Where it's recruiting

Maryland

Baltimore

New York

New York

Source: ClinicalTrials.gov · NCT07778459 · last updated 2026-08-21

Expanding HOPE Liver · TrialPath